{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:42:08Z","timestamp":1793396528252,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bjid.2022.102347","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T01:35:32Z","timestamp":1647480932000},"page":"102347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-6837","authenticated-orcid":false,"given":"Maicon","family":"Falavigna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-7572","authenticated-orcid":false,"given":"Karlyse Claudino","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-4722","authenticated-orcid":false,"given":"Alexandre Naime","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Prehn","family":"Zavascki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-6156","authenticated-orcid":false,"given":"Ana Catharina de Seixas Santos","family":"Nastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane Machado","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1833-8221","authenticated-orcid":false,"given":"Cinara","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-540X","authenticated-orcid":false,"given":"D\u00e9bora Dalmas","family":"Gr\u00e4f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2699-4344","authenticated-orcid":false,"given":"Flavio Adsuara","family":"Cadegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-1015","authenticated-orcid":false,"given":"H\u00e9lio Penna","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-5178","authenticated-orcid":false,"given":"Jos\u00e9 Tadeu","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-1384","authenticated-orcid":false,"given":"Juliana Carvalho","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano Cesar Pontes","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Mihailenko Chaves","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcone Lima","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatriz Gandra de Souza","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura Salaroli","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian de Freitas Dal Ben","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-060X","authenticated-orcid":false,"given":"Ricardo Souza","family":"Heinzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemeri Maurici","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubens Belfort","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cimerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7908-4213","authenticated-orcid":false,"given":"Ver\u00f4nica","family":"Colpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-3601","authenticated-orcid":false,"given":"Viviane Cordeiro","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-8509","authenticated-orcid":false,"given":"Carlos Roberto Ribeiro","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2022.102347_bib0001","unstructured":"Weekly epidemiological update on COVID-19 \u201322 February 2022. 2022. https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19\u201422-february-2022 (accessed February 2022)."},{"key":"10.1016\/j.bjid.2022.102347_bib0002","unstructured":"Painel Coronav\u00edrus. 2022. https:\/\/covid.saude.gov.br\/(accessed February 2022)."},{"key":"10.1016\/j.bjid.2022.102347_bib0003","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s13054-020-03194-w","article-title":"International variation in the management of severe COVID-19 patients","volume":"24","author":"Azoulay","year":"2020","journal-title":"Critical Care"},{"key":"10.1016\/j.bjid.2022.102347_bib0004","series-title":"Diretrizes Brasileiras para Tratamento Hospitalar do Paciente com COVID-19 \u2013 Cap\u00edtulo 2: Tratamento Farmacol\u00f3gico","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2020.09.037","article-title":"Developing trustworthy recommendations as part of an urgent response (1\u20122 weeks): a GRADE concept paper","volume":"129","author":"Akl","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bjid.2022.102347_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Schunemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bjid.2022.102347_bib0007","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jclinepi.2021.03.034","article-title":"Getting trustworthy guidelines into the hands of decision-makers and supporting their consideration of contextual factors for implementation globally: recommendation mapping of COVID-19 guidelines","volume":"135","author":"Lotfi","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bjid.2022.102347_bib0008","first-page":"166","article-title":"Diretrizes para o tratamento farmacol\u00f3gico da COVID-19. Consenso da Associa\u00e7\u00e3o de Medicina Intensiva Brasileira, da Sociedade Brasileira de Infectologia e da Sociedade Brasileira de Pneumologia e Tisiologia","volume":"32","author":"Falavigna","year":"2020","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.bjid.2022.102347_bib0009","first-page":"37","article-title":"COVID-19: Summary Recommendations - Brazilian Medical Association (AMB)","volume":"2","author":"Tanni","year":"2021","journal-title":"World Med J"},{"key":"10.1016\/j.bjid.2022.102347_bib0010","series-title":"Caring for people with COVID-19 - Supporting Australia's Healthcare Professionals with Continually Updated Evidence-Based Clinical Guidelines","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00048-2021","article-title":"Management of hospitalised adults with Coronavirus Disease 19 (COVID-19): a European Respiratory Society living guideline","volume":"57","author":"Chalmers","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2022.102347_bib0012","series-title":"IDSA Guidelines on the Treatment and Management of Patients with COVID-19","author":"Bhimraj","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0013","series-title":"COVID-19 Rapid Guideline: Managing COVID-19","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0014","series-title":"COVID-19 Treatment Guidelines","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0015","series-title":"Therapeutics and COVID-19","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0016","article-title":"Pan American Health Organization - PAHO, Ongoing living update of potential COVID-19 therapeutics options: summary of evidence","year":"2021","journal-title":"Rapid Rev."},{"issue":"Suppl 2","key":"10.1016\/j.bjid.2022.102347_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00106-021-01070-9","volume":"69","author":"Klimek","year":"2021","journal-title":"HNO"},{"key":"10.1016\/j.bjid.2022.102347_bib0018","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Schunemann","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.bjid.2022.102347_bib0019","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bjid.2022.102347_bib0020","unstructured":"Janssen Research & Development, LLC. A study of rivaroxaban to reduce the risk of major venous and arterial thrombotic events, hospitalization and death in medically ill outpatients with acute, symptomatic coronavirus disease 2019 (COVID-19) infection (PREVENT-HD) NCT04508023. 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04508023?term=NCT04508023&draw=2&rank=1 (accessed September 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0021","series-title":"COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80","author":"Frank","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0022","series-title":"Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 (APOLLO)","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0023","series-title":"GRADE Handbook. Handbook for Grading the Quality of Evidence and the Strength of Recommendations using the GRADE Approach","author":"Sch\u00fcnemann","year":"2013"},{"key":"10.1016\/j.bjid.2022.102347_bib0024","series-title":"Diretrizes: COVID-19","year":"2021"},{"key":"10.1016\/j.bjid.2022.102347_bib0025","unstructured":"Infectious Diseases Society of America (IDSA). Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. 2020. https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/(accessed May 2020)."},{"key":"10.1016\/j.bjid.2022.102347_bib0026","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2020.4742","article-title":"Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics","volume":"323","author":"Kalil","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.bjid.2022.102347_bib0027","unstructured":"Recovery trial. https:\/\/www.recoverytrial.net\/(accessed November 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0028","unstructured":"Who COVID-19 Solidarity Therapeutics Trial. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments (accessed November 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0029","unstructured":"Coaliz\u00e3o COVID Brasil. https:\/\/www.hcor.com.br\/imprensa\/noticias\/coalizao-covid-brasil-convida-medicos-pesquisadores-e-profissionais-da-saude-para-pesquisa-sobre-tratamento-de-coronavirus\/(accessed November 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0030","unstructured":"Togheter clinical trials. https:\/\/www.togethertrial.com\/(accessed November 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0031","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients","volume":"386","author":"Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2022.102347_bib0032","unstructured":"Merck. At the interim analysis, 7.3 percent of patients who received molnupiravir were hospitalized through day 29, compared with 14.1 percent of placebo-treated patients who were hospitalized or died. https:\/\/www.merck.com\/news\/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat\/(accessed November 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0033","unstructured":"Pfizer. Pfizer's novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2\/3 EPIC-HR study. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizers-novel-covid-19-oral-antiviral-treatment-candidate (accessed January 2022)."},{"key":"10.1016\/j.bjid.2022.102347_bib0034","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2214-109X(21)00501-5","article-title":"Fluvoxamine for outpatients with COVID-19: where do we stand?","volume":"10","author":"Berwanger","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.bjid.2022.102347_bib0035","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2214-109X(21)00448-4","article-title":"Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the Together randomised, platform clinical trial","volume":"10","author":"Reis","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.bjid.2022.102347_bib0036","unstructured":"AZD7442 PROVENT phase III prophylaxis trial met primary endpoint in preventing COVID-19. https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2021\/azd7442-prophylaxis-trial-met-primary-endpoint.html (accessed November 2021)."},{"key":"10.1016\/j.bjid.2022.102347_bib0037","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with Covid-19 Pneumonia","volume":"385","author":"Guimar\u00e3es","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2022.102347_bib0038","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"COV-BARRIER Study Group. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867022000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867022000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:58:07Z","timestamp":1761407887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867022000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1413867022000356"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2022.102347","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2022.102347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102347"}}